January 4, 2026
SOHO 2025 Educational Resources Leukemia Meetings / Conferences Myelodysplastic Syndromes News

Improving Outcomes in CHIP/CCUS with Dr. Borate

This Meet the Professor session was delivered by Uma Borate, MD, MS, an associate professor at the Ohio State University Comprehensive Cancer Center,

Read More
Leukemia Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Myelodysplastic Syndromes News

FDA accepts BLA for Orca-T in hematological malignancies

The US Food and Drug Administration (FDA) accepted for priority review the Biologics License Application (BLA) seeking approval for Orca-T (Orca-T), an investigational

Read More
Leukemia News SOHO 2025 Educational Resources Acute Myeloid Leukemia Meetings / Conferences News

Future Role of CPX-351 and CPX-351-Based Combinations

In this Meet the Professor session in acute myeloid leukemia, Jeffrey Lancet, MD, chair of the Department of Malignant Hematology at the Moffitt

Read More
Lymphoma Mantle Cell Lymphoma News

FDA grants breakthrough therapy designation to sonrotoclax in relapsed or refractory MCL

The United States Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for sonrotoclax, a next-generation investigational BCL2 inhibitor, for adult patients with

Read More
Leukemia News SOHO 2025

Drs. Kantarjian and Mauro discuss ELVN-001 in CML

In this video interview, Hagop Kantarjian, MD, speaks with Michael Mauro, MD, leader of the CML program at Memorial Sloan Kettering Cancer Center,

Read More
Leukemia Acute Myeloid Leukemia SOHO Insider Podcast

Dr. Eytan Stein joins Dr. Saad Usmani on SOHO Insider podcast

Saad Usmani, MD, chief of the myeloma service and Eytan Stein, MD, chief of the leukemia service, both from Memorial Sloan Kettering Cancer

Read More
Lymphoma News SOHO 2025 News

BTK ‘degrader’ bexdeg shines in Waldenström macroglobulinemia

Attendees of SOHO 2025 will get a closer look at positive early safety and efficacy data for the novel Bruton’s tyrosine kinase (BTK)-targeted

Read More
SOHO 2025 Ambassador Program News

The global impact of SOHO

With more than 10,500 global members, SOHO is poised to educate hematologic oncologists from every corridor of the Earth.

Read More
Leukemia News SOHO 2025 Leukemia Chronic Lymphocytic Leukemia News

22-year study highlights disparities in CLL mortality rates

Death from chronic lymphocytic leukemia (CLL) in the U.S. has been declining, but disparities in outcomes persist, according to a population study of

Read More
Lymphoma News Leukemia News SOHO 2025 News Young Investigator Program

Next-gen hem/oncs engage in new CLL/SLL educational pilot program at SOHO 2025

The Society of Hematologic Oncology (SOHO) created the Young Investigator Program (YIP) to support the training and development of young investigators and to promote quality

Read More